Drugs / PMK-S005
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01762397 | Dec 2012 → May 2013 | gastric ulcer, gastritis | PharmaKing | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02342470 | Nov 2014 → Dec 2017 | peptic ulcer disease | PharmaKing | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PMK-S005 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02342470 ↗ |
| Route | Oral | “PMK-S005 After Oral Administration” NCT01762397 ↗ |